Bullous pemphigoid: Etiology, pathogenesis, and inducing factors: Facts and controversies

Clinics in Dermatology

Volumn 31, Issue 4, 2013, Pages 391-399

  Lo Schiavo, Ada ^a   Ruocco, Eleonora ^a   Brancaccio, Gabriella ^a   Caccavale, Stefano ^a   Ruocco, Vincenzo ^a   Wolf, Ronni ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; AMPICILLIN; ANTIGEN; AUTOANTIBODY; AUTOANTIGEN; BENZYL BENZOATE; BP180 ANTIGEN; BULLOUS PEMPHIGOID ANTIGEN 1; BUMETANIDE; CAPTOPRIL; CEFALEXIN; CEPHALOSPORIN DERIVATIVE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; EFALIZUMAB; ENALAPRIL; ETANERCEPT; FLUOROURACIL; FUROSEMIDE; IBUPROFEN; INFLUENZA VACCINE; NIFEDIPINE; PENICILLAMINE; PENICILLIN DERIVATIVE; PHENACETIN; PROTEINASE; SPIRONOLACTONE; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; AUTOIMMUNITY; BLISTER; BULLOUS PEMPHIGOID; BURN; COMPLEMENT ACTIVATION; DRUG INDUCED BULLOUS PEMPHIGOID; DRUG INDUCED DISEASE; EOSINOPHIL; FOOD; HUMAN; IMMUNE DEFICIENCY; INFECTION; INFLAMMATION; MAST CELL DEGRANULATION; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RADIOTHERAPY; RISK FACTOR; SURGERY; TRANSPLANTATION; ULTRAVIOLET RADIATION; VACCINATION;

AUTOANTIBODIES; AUTOANTIGENS; DIET; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HLA-DQ BETA-CHAINS; HUMANS; PEMPHIGOID, BULLOUS;

EID: 84879599058     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2013.01.006     Document Type: Article

References (74)

1. Kasperkiewicz M., Zillikens D., Schmidt E. Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity 2012, 45:55-70.
2. Di Zenzo G., Marazza G., Borradori L. Bullous pemphigoid: physiopathology, clinical features and management. Adv Dermatol 2007, 23:257-288.
3. Patricio P., Ferreira C., Gomes M.M., Filipe P. Autoimmune bullous dermatoses: a review. Ann N Y Acad Sci 2009, 1173:203-210.
4. Di Zenzo G., Thoma-Uszynski S., Fontao L., et al. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin Immunol 2008, 12:415-426.
5. Heimbach L., Li Z., Berkowitz P., et al. The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid. J Biol Chem 2011, 286:15003-15009.
6. Kasperkiewicz M., Zillikens D. The pathophysiology of bullous pemphigoid. Clin Rev Allergy Immunol 2007, 33:67-77.
7. Hertl M., Eming R., Veldman C. T cell control in autoimmune bullous skin disorders. J Clin Invest 2006, 116:1159-1166.
8. Grando S.A. Pemphigus autoimmunity: hypothesis and realities. Autoimmunity 2012, 45:7-35.
9. Rensing-Ehl A., Gaus B., Bruckner-Tuderman L., Martin S.F. Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid. Exp Dermatol 2007, 16:13-21.
10. Shlomchik M.J. Activating systemic autoimmunity: B's, T's, and tolls. Curr Opin Immunol 2009, 21:626-633.
11. Toosi S., Bystryn J.C. Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid. Med Hypothesis 2010, 74:727-728.
12. Arakawa M., Dainichi T., Ishii N., et al. Lesional Th17 cells and regulatory T cells in bullous pemphigoid. Exp Dermatol 2011, 20:1011-1037.
13. Torchia D., Caproni M., Volpi W., Fabbri P. Naturally occurring regulatory T cells in mucous membrane pemphigoid lesions. Acta Dermatovenerol Alp Panonica Adriat 2009, 18:3-6.
14. Liu Z., Giudice G.J., Swartz S.J., et al. The role of complement in experimental bullous pemphigoid. J Clin Invest 1995, 95:1539-1544.
15. Iwata Y., Komura K., Kodera M., et al. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid. Arch Dermatol 2008, 144:41-48.
16. Marzano A.V., Tedeschi A., Fanoni D., et al. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications. Br J Dermatol 2009, 160:266-272.
17. Venning V.A., Wojnarowska F. Induced bullous pemphigoid. Br J Dermatol 1995, 132:831-832.
18. Vassileva S. Drug-induced pemphigoid: bullous and cicatricial. Clin Dermatol 1998, 16:379-387.
19. Ruocco V., Sacerdoti G. Pemphigus and bullous pemphigoid due to drugs. Int J Dermatol 1991, 30:307-312.
20. Popadic S., Skiljevic D., Medenica L. Bullous pemphigoid induced by penicillamine in a patient with Wilson disease. Am J Clin Dermatol 2009, 10:36-38.
21. Mallet L., Cooper J.W., Thomas J. Bullous pemphigoid associated with captopril. DICP 1989, 23:63.
22. Wozniak K., Kowalewski C., Hashimoto T., Ishii N., Glinska-Wielochowska M., Schwartz R.A. Penicillin-induced anti-p200 pemphigoid: an unusual morphology. Acta Derm Venereol 2006, 86:443-446.
23. Hodak E., Ben-Shetrit A., Ingber A., Sandbank M. Bullous pemphigoid-an adverse effect of ampicillin. Clin Exp Dermatol 1990, 15:50-52.
24. Walsh S.R., Hogg D., Mydlarski P.R. Bullous pemphigoid: from bench to bedside. Drugs 2005, 65:905-926.
25. Durdu M., Baba M., Seçkin D. A case of bullous pemphigoid induced by aspirin. J Am Acad Dermatol 2011, 65:443-444.
26. Smith E.P., Taylor T.B., Meyer L.J., Zone J.J. Antigen identification in drug-induced bullous pemphigoid. J Am Acad Dermatol 1993, 29:879-882.
27. Laing V.B., Sheretz E.F., Flowers F.P. Pemphigoid-like bullous eruption related to ibuprofen. J Am Acad Dermatol 1998, 19:91-94.
28. Pompeová L. Bullous pemphigoid induced by taking Brufen. Cesk Dermatol 1981, 56:256-258.
29. Ameen M., Harman K.E., Black M.M. Pemphigoid nodularis associated with nifedipine. Br J Dermatol 2000, 142:575-577.
30. Brenner S., Ruocco V., Bialy-Golan A., et al. Pemphigus and pemphigoid-like effects of nifedipine on in vitro cultured normal human skin explants. Int J Dermatol 1999, 38:36-40.
31. Kluk J., Goulding J.M., Bhat J., Finch T.M. Drug-induced bullous pemphigoid: cases triggered by intravenous iodine and etanercept. Clin Exp Dermatol 2011, 36:871-873.
32. Bordignon M., Belloni-Fortina A., Pigozzi B., Tarantello M., Alaibac M. Bullous pemphigoid during long-term TNF-alpha blocker therapy. Dermatology 2009, 219:357-358.
33. Toosi S., Bystryn J.C. Does adalimumab cause bullous pemphigoid?. Clin Exp Dermatol 2010, 35:795.
34. Duong T.A., Buffard V., André C., et al. Efalizumab-induced bullous pemphigoid. J Am Acad Dermatol 2010, 62:161-162.
35. Cusano F., Iannazzone S.S., Riccio G., Piccirillo F. Coexisting bullous pemphigoid and psoriasis successfully treated with etanercept. Eur J Dermatol 2010, 20:520.
36. Yamauchi P.S., Lowe N.J., Gindi V. Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol 2006, 54:121-122.
37. Walmsley N., Hampton P. Bullous pemphigoid triggered by swine flu vaccination: case report and review of vaccine triggered pemphigoid. J Dermatol Case Rep 2011, 5:74-76.
38. García-Doval I., Mayo E., Nogueira Fariña J., Cruces M.J. Bullous pemphigoid triggered by influenza vaccination? Ecological study in Galicia, Spain. Br J Dermatol 2006, 155:820-823.
39. Mérida C., Martínez-Escribano J.A., Frías J.F., Sánchez-Pedreño P., Corbalán R. Bullous pemphigoid in an infant after vaccination. Actas Dermosifiliogr 2005, 96:255-257.
40. Baykal C., Okan G., Sarica R. Childhood bullous pemphigoid developed after the first vaccination. J Am Acad Dermatol 2001, 44:348-350.
41. Lee J.J., Downham T.F. Furosemide-induced bullous pemphigoid: case report and review of literature. J Drugs Dermatol 2006, 5:562-564.
42. Baz K., Ikizoglu G., Kaya T.I., Koca A. Furosemide-induced bullous pemphigoid. J Eur Acad Dermatol Venereol 2002, 16:81-82.
43. Kashihara M., Danno K., Miyachi Y., Horiguchi Y., Imamura S. Bullous pemphigoid-like lesions induced by phenacetin. Report of a case and an immunopathologic study. Arch Dermatol 1984, 120:1196-1199.
44. Czechowicz R.T., Reid C.M., Warren L.J., Weightman W., Whitehead F.J. Bullous pemphigoid induced by cephalexin. Australas J Dermatol 2001, 42:132-135.
45. Boulinguez S., Bernard P., Bedane C., le Brun V., Bonnetblanc J.M. Bullous pemphigoid induced by bumetanide. Br J Dermatol 1998, 138:548-549.
46. Modeste A.B., Cordel N., Courville P., Gilbert D., Lauret P., Joly P. Bullous pemphigoid induced by spironolactone. Ann Dermatol Venereol 2002, 129:56-58.
47. Rault S., Grosieux-Dauger C., Verraes S., Bernardeau K., Durlach A., Bernard P. Bullous pemphigoid induced by fluoxetine. Br J Dermatol 1999, 141:755-756.
48. Millard T.P., Smith H.R., Black M.M., Barker J.N. Bullous pemphigoid developing during systemic therapy with chloroquine. Clin Exp Dermatol 1999, 24:263-265.
49. Wijeratne C., Webster P. Risperidone and bullous pemphigoid. Am J Psychiatry 1996, 153:735.
50. Khandpur S., Verma P. Bullous pemphigoid. Indian J Dermatol Venereol Leprol 2011, 77:450-455.
51. Ruocco V., Brunetti G., Puca R.V., Ruocco E. The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites. J Eur Acad Dermatol Venereol 2009, 23:1364-1373.
52. Isohashi F., Konishi K., Umegaki N., Tanei T., Koizumi M., Yoshioka Y. A case of bullous pemphigoid exacerbated by irradiation after breast conservative radiotherapy. Jpn J Clin Oncol 2011, 41:811-813.
53. Srifi N., Benomar S., Zaghba N., et al. Generalized bullous pemphigoid induced by radiotherapy. Ann Dermatol Venereol 2011, 138:311-314.
54. Mul V.E., Verschueren T.A., van Geest A.J., Baumert B.G. Bullous pemphigoid (BP) induced by radiotherapy. Radiother Oncol 2007, 82:105.
55. Muramatsu T., Yamashina Y., Shirai T., Onishi T. UVB irradiation reduces the expression of pemphigoid antigens in organ-cultured normal human skin. Arch Dermatol Res 1994, 286:142-144.
56. Washio H., Hara H., Suzuki H., Yoshida M., Hashimoto T. Bullous pemphigoid in psoriasis lesions after UVA radiation. Acta Derm Venereol 2005, 85:561-563.
57. Fabbri P. Pemfigoide Bolloso. Immunodermatologia 2nd ed. ISED:4:291-304.
58. Kao C.L., Krathen R.A., Wolf J.E., Fuerst J.F., Hsu S. Psoralen plus ultraviolet A-induced bullous pemphigoid. J Drugs Dermatol 2008, 7:695-696.
59. Barnadas M.A., Gilaberte M., Pujol R., Agustí M., Gelpí C., Alomar A. Bullous pemphigoid in a patient with psoriasis during the course of PUVA therapy: study by ELISA test. Int J Dermatol 2006, 45:1089-1092.
60. Sacher C., König C., Scharffetter-Kochanek K., Krieg T., Hunzelmann N. Bullous pemphigoid in a patient treated with UVA-1 phototherapy for disseminated morphea. Dermatology 2001, 202:54-57.
61. Balato N., Ayala F., Patruno C., Turco P., Ruocco V. Bullous pemphigoid induced by a thermal burn. Int J Dermatol 1994, 33:55-56.
62. Bachmeyer C., Cabanne-Hamy A., Moguelet P., Doizi S., Callard P. Bullous pemphigoid after boiling water burn. South Med J 2010, 103:1175-1177.
63. Xu H.H., Xiao T., He C.D., et al. Bullous pemphigoid triggered by a boiling water burn. Eur J Dermatol 2008, 18:466-467.
64. Kluger N., Laipio J., Virolainen S., Ranki A., Koljonen V. A fatal case of hot air sauna burn in an elderly patient initially misdiagnosed as bullous pemphigoid. Acta Derm Venereol 2011, 91:732-733.
65. Nozu T., Mita H. Bullous pemphigoid and percutaneous endoscopic gastrostomy. Intern Med 2010, 49:971-975.
66. Batalla A., Peón G., De la Torre C. Localized bullous pemphigoid at urostomy site. Indian J Dermatol Venereol Leprol 2011, 77:625.
67. Torchia D., Caproni M., Ketabchi S., Antiga E., Fabbri P. Bullous pemphigoid initially localized around urostomy. Int J Dermatol 2006, 45:1387-1389.
68. Yesudian P.D., Dobson C.M., Ahmad R., Azurdia R.M. Trauma-induced bullous pemphigoid around venous access site in a haemodialysis patient. Clin Exp Dermatol 2002, 27:70-72.
69. Neville J.A., Yosipovitch G. Flare of bullous pemphigoid in surgically treated skin. Cutis 2005, 75:169-170.
70. Chen T.J., Lai P.C., Yang L.C., Kuo T.T., Hong H.S. Bullous pemphigoid in a renal transplant recipient: a case report and review of the literature. Am J Clin Dermatol 2009, 10:197-200.
71. Kerkar N., Cohen S., Dugan C., et al. Bullous pemphigoid after liver transplantation for liver failure. Liver Transpl 2006, 12:1705-1710.
72. Drago F., Nozza P., Casazza S., Brusati C., Bandelloni R., Rebora A. Human herpesviruses in bullous pemphigoid lesions. Br J Dermatol 2005, 152:375-376.
73. Sagi L., Baum S., Agmon-Levin N., et al. Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature. Autoimmun Rev 2011, 10:527-535.
74. Fedeles F., Murphy M., Rothe M.J., Grant-Kels J.M. Nutrition and bullous skin diseases. Clin Dermatol 2010, 28:627-643.